STOCK TITAN

Milestone Scientific, Inc. - MLSS STOCK NEWS

Welcome to our dedicated page for Milestone Scientific news (Ticker: MLSS), a resource for investors and traders seeking the latest updates and insights on Milestone Scientific stock.

Milestone Scientific, Inc. (NASDAQ: MLSS) is a pioneering company in the field of medical and dental anesthesia. The company focuses on the development, manufacture, marketing, and sale of computer-controlled local anesthetic delivery (C-CLAD) systems designed to provide improved and painless local anesthetic delivery. These systems are marketed under various trademarks for different applications. For dentistry, the products are known as CompuDent™ and STA™ (Single Tooth Anesthesia) System. These innovative devices allow for painless injections during a wide range of dental procedures, from routine cleanings to complex surgeries involving implants, root canals, and crowns.

For medical applications, Milestone Scientific offers similar technology under the CompuMed™ trademark. Their products are used across various medical disciplines, including plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, and orthopedics. The company's advanced anesthetic delivery systems are sold both in the United States and in over 25 countries worldwide, highlighting their global reach and impact.

Besides their core product offerings, Milestone Scientific also provides The Wand™, a handpiece that allows for almost painless injections, enhancing patient comfort significantly.

The firm's operations are divided into two main segments: Dental and Medical. Geographically, all operations are concentrated in the United States, but their products are influential on a global scale.

Recent Achievements:

  • Successful evaluations by prominent medical professionals, such as Dr. Matthew Stottle of Omaha Pain Physicians, achieving 100% success rates.
  • Acceleration in reimbursement claims submission for the CompuFlo® Epidural System.

For more information or inquiries, Milestone Scientific can be contacted through Crescendo Communications, LLC via email at mlss@crescendo-ir.com or by phone at 212-671-1020.

Rhea-AI Summary

Milestone Scientific (NYSE:MLSS) announced the successful commencement of sales for its CompuFlo Epidural disposables at a prominent Southern California medical center recognized for maternity care. This facility is part of a large healthcare system that delivers over 100,000 babies annually. CEO Arjan Haverhals highlighted the company's growing presence in the labor market. Additionally, the AMA has approved a new CPT code for the CompuFlo system, expected to enhance commercialization in various markets, including pain management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.72%
Tags
none
-
Rhea-AI Summary

Milestone Scientific (NYSE:MLSS) announced the issuance of a new Category III CPT code by the American Medical Association for its CompuFlo Epidural System. This code, effective January 1, 2023, aims to enhance reimbursement opportunities for epidural procedures. The CPT Editorial Panel validated the technology based on clinical studies, which indicate improved accuracy and reduced complications in pain management. CEO Arjan Haverhals highlighted the potential of this development to accelerate commercial rollout and increase market penetration, especially in the chronic pain segment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.48%
Tags
none
-
Rhea-AI Summary

Milestone Scientific (NYSE: MLSS) announced the initiation of sales for its CompuFlo Epidural instrument at a prominent veterinary and academic institution. This follows a successful evaluation of the device in maxillary nerve block procedures in horses. The instrument enhances accuracy in nerve block applications and aims to improve the training of upcoming veterinarians. CEO Arjan Haverhals expressed confidence in the commercialization of their technology across various medical sectors, emphasizing the potential for improved patient outcomes and broad market applicability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.17%
Tags
none
Rhea-AI Summary

Milestone Scientific (NYSE: MLSS) has appointed Ms. Benedetta Casamento to its Board of Directors. Casamento, a retail consultant with extensive experience in finance and brand management, was previously Chairman and President of Allyke, Inc., and has held top roles at Calypso St. Barth and The Talbots. Her expertise in marketing and operations is expected to bolster Milestone's growth strategies, particularly for its CompuFlo® Epidural and CathCheck™ products. Chairman Leslie Bernhard expressed confidence in her potential contributions to the company’s future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.15%
Tags
management
-
Rhea-AI Summary

Milestone Scientific Inc. (NYSE: MLSS) reported Q1 2022 revenues of $2.7 million, down from $2.9 million in Q1 2021. The decrease was attributed to prior year's pent-up demand. Despite the decline, the company is advancing sales efforts for its CompuFlo® Epidural and CathCheck™ systems and has secured vendor status with a major Northeast hospital. Operating loss rose to $(1.9) million. However, Milestone maintains a strong balance sheet with $13.3 million in cash and is well-positioned for growth, particularly in the dental segment amid expanding distribution partnerships.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.81%
Tags
none
-
Rhea-AI Summary

Milestone Scientific Inc. (NYSE:MLSS) will host a conference call on May 17, 2022, at 8:30 AM ET to discuss its financial results for Q1 2022, ending March 31. The call aims to provide insights into the company's corporate progress and developments. U.S. callers can join by calling toll-free 888-506-0062, and international callers can reach +1 973-528-0011. An audio replay will be available until May 31, 2022. Milestone Scientific specializes in innovative injection technologies, enhancing patient comfort and safety.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
Rhea-AI Summary

Milestone Scientific (NYSE:MLSS) announced that its President and CEO, Arjan Haverhals, will present at the Noble Capital Markets Eighteenth Annual Investor Conference on April 21, 2022, at 11:30 am ET in Seminole Ballroom D. Investors can meet management at breakout sessions on April 20. A video webcast of the presentation will be available the following day on the company’s website and other platforms for 90 days. Milestone specializes in advanced drug delivery systems, enhancing patient comfort and safety through innovative technologies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Milestone Scientific Inc. (NYSE: MLSS) has formed a strategic partnership with Keystone Dental Group to enhance the distribution of its STA Single Tooth Anesthesia® system in the dental implant market. This collaboration leverages Keystone's sales force of over 60 representatives to expand reach into surgical specialties. Additionally, Milestone has partnered with American Independent Dental Alliance to access over 1,000 dental practices, and with Esthetic Professionals to enhance dental education through hands-on training. These initiatives aim to drive growth in the expanding DSO market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Summary

Milestone Scientific (NYSE: MLSS) has begun sales of its CompuFlo Epidural and CathCheck Verification System to a leading medical center recognized as one of the World’s Best Hospitals-USA for four consecutive years. The approval comes after a successful evaluation and emphasizes the systems' clinical advantages in improving accuracy and reducing complication rates during epidural procedures. These innovations aim to drive better health outcomes at lower costs, with potential economic benefits for healthcare institutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Milestone Scientific (NYSE: MLSS) reported a remarkable 90% year-over-year revenue growth for 2021, totaling $10.3 million, surpassing previous guidance and pre-pandemic levels. The company highlights strong dental division performance and profitability with high gross margins. Expansion in medical distribution includes new partnerships with pain management clinics and hospitals. Despite challenges from the pandemic, particularly in labor and delivery departments, Milestone is optimistic about regaining momentum. The company holds a robust cash position of $14.8 million to fuel growth initiatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.26%
Tags
none

FAQ

What is the current stock price of Milestone Scientific (MLSS)?

The current stock price of Milestone Scientific (MLSS) is $0.925 as of December 20, 2024.

What is the market cap of Milestone Scientific (MLSS)?

The market cap of Milestone Scientific (MLSS) is approximately 63.1M.

What does Milestone Scientific, Inc. do?

Milestone Scientific develops, manufactures, markets, and sells computer-controlled local anesthetic delivery systems for medical and dental applications.

What are the main products offered by Milestone Scientific?

The main products include CompuDent™, STA™ System, CompuMed™, and The Wand™, catering to various dental and medical procedures.

Where are Milestone Scientific’s products sold?

Their products are sold in the United States and in over 25 countries worldwide.

What recent achievements has Milestone Scientific accomplished?

Recent achievements include a 100% success rate in evaluations by Dr. Matthew Stottle and accelerated reimbursement claims for the CompuFlo® Epidural System.

What are the main segments of Milestone Scientific’s business?

The two main segments are Dental and Medical.

How can Milestone Scientific be contacted?

They can be contacted through Crescendo Communications, LLC via email at mlss@crescendo-ir.com or by phone at 212-671-1020.

What is The Wand™?

The Wand™ is a handpiece provided by Milestone Scientific that enables dentists to deliver painless injections for various dental procedures.

What is the STA™ System?

The STA™ System is the Single Tooth Anesthesia system suitable for all dental procedures, marketed under Milestone Scientific’s portfolio.

Which medical disciplines use Milestone Scientific’s systems?

Their systems are used in plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, orthopedics, and other disciplines.

What is CompuMed™?

CompuMed™ is the trademark under which Milestone Scientific markets its computer-controlled anesthetic delivery systems for medical applications.

Milestone Scientific, Inc.

NYSE:MLSS

MLSS Rankings

MLSS Stock Data

63.09M
65.92M
15.5%
5.47%
0.15%
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
LIVINGSTON